Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
147.03
-0.74 (-0.50%)
At close: Jan 17, 2025, 4:00 PM
147.30
+0.27 (0.18%)
After-hours: Jan 17, 2025, 7:57 PM EST
Johnson & Johnson Market Cap
Johnson & Johnson has a market cap or net worth of $353.99 billion as of January 17, 2025. Its market cap has decreased by -8.65% in one year.
Market Cap
353.99B
Enterprise Value
369.45B
1-Year Change
-8.65%
Ranking
Category
Stock Price
$147.03
Market Cap Chart
Since May 14, 2001, Johnson & Johnson's market cap has increased from $136.61B to $353.99B, an increase of 159.13%. That is a compound annual growth rate of 4.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 353.99B | 1.67% |
| Dec 31, 2024 | 348.19B | -7.72% |
| Dec 29, 2023 | 377.32B | -18.30% |
| Dec 30, 2022 | 461.85B | 2.55% |
| Dec 31, 2021 | 450.36B | 8.70% |
| Dec 31, 2020 | 414.31B | 7.92% |
| Dec 31, 2019 | 383.91B | 10.92% |
| Dec 31, 2018 | 346.11B | -7.79% |
| Dec 29, 2017 | 375.36B | 19.76% |
| Dec 30, 2016 | 313.43B | 10.28% |
| Dec 31, 2015 | 284.22B | -2.90% |
| Dec 31, 2014 | 292.70B | 13.27% |
| Dec 31, 2013 | 258.42B | 33.02% |
| Dec 31, 2012 | 194.27B | 8.47% |
| Dec 30, 2011 | 179.09B | 5.44% |
| Dec 31, 2010 | 169.86B | -4.42% |
| Dec 31, 2009 | 177.71B | 7.05% |
| Dec 31, 2008 | 166.00B | -13.03% |
| Dec 31, 2007 | 190.88B | -0.28% |
| Dec 29, 2006 | 191.42B | 7.06% |
| Dec 30, 2005 | 178.79B | -5.00% |
| Dec 31, 2004 | 188.21B | 22.75% |
| Dec 31, 2003 | 153.33B | -3.90% |
| Dec 31, 2002 | 159.55B | -11.43% |
| Dec 31, 2001 | 180.14B | 31.87% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.70B |
| UnitedHealth Group | 474.29B |
| Novo Nordisk | 368.86B |
| AbbVie | 304.51B |
| Merck & Co. | 253.32B |
| Thermo Fisher Scientific | 214.99B |
| Intuitive Surgical | 209.05B |
| AstraZeneca | 205.71B |